Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-12

Clinical Trial Update: Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing adjuvant chemotherapy, chemoradiotherapy, and surgery alone for pN1-2 (pT1b-3N1-2M0) esophageal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING